Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBX.L Regulatory News (CBX)

  • There is currently no data for CBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Annual General Meeting

13 Feb 2023 17:50

RNS Number : 7829P
Cellular Goods PLC
13 February 2023
 

Press release

 

13 February 2023

 

 

Cellular Goods PLC

 

('Cellular Goods' or 'the Company')

 

Results of Annual General Meeting

 

Cellular Goods (LSE: CBX), a UK-based wellness company providing premium consumer products formulated with lab-produced cannabinoids, is pleased to announce that all resolutions proposed at the Annual General Meeting held earlier today were duly passed on a show of hands.

 

For further information please contact:

Cellular Goods

Darcy Taylor

Chairman and interim CEO

Neil Thapar

Investor Relations

via Tancredi +44 207 887 7633

 

+44 787 645 5323

Tennyson Securities

Corporate Broker & Adviser

Peter Krens

Alan Howard

 

+44 207 186 9030

Novum Securities

 

Corporate Broker

Colin Rowbury

Jon Belliss

 

 

+44 207 399 9427

Tancredi Intelligent Communication

Media Relations

Helen Humphrey

Charlie Hobbs

cellulargoods@tancredigroup.com

 

+44 744 922 6720

+44 789 755 7112

 

About Cellular Goods PLC:

Cellular Goods is a UK-based wellness company that provides premium products based on lab-made cannabinoids. It was established in August 2018 to develop efficacy-led and research-backed cannabinoid-powered wellness products. The initial focus is on three product verticals: Feel Better, Look Better and Function Better. These three verticals encompass Cellular Goods' premium CBG skincare and CBD wellness with the first products launched in December 2021. The Company's shares are listed on the main market of the London Stock Exchange. www.cellular-goods.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUOSBROWUUAAR
Date   Source Headline
7th Nov 20067:02 amRNSDirector/PDMR Shareholding
25th Sep 20069:11 amRNSInterim Results
9th Aug 200610:43 amRNSAGM Statement
26th Jun 20067:01 amRNSFinal Results
28th Apr 200610:10 amRNSGrant of Options
21st Apr 200611:25 amRNSDirector/PDMR Shareholding
3rd Mar 20061:00 pmRNSAdmission to AIM-Amendment
3rd Mar 200612:23 pmRNSAdmission to AIM
7th Feb 20064:55 pmRNSSchedule 1 - Cubus Lux
7th Feb 20067:01 amRNSAcquisition
30th Sep 20051:33 pmRNSInterim Results
25th Jul 20053:25 pmRNSDirector/PDMR Shareholding
20th Jul 20057:00 amRNSOpening of a Third Casino
19th Jul 20056:09 pmRNSChange of Adviser
19th Jul 20056:09 pmRNSDirectorate Change
21st Mar 200512:07 pmRNSAnnual Report and Accounts
6th Jan 20055:52 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.